NOT-AI-01-019: RFP ANNOUNCEMENT: HIV VACCINE DESIGN AND DEVELOPMENT TEAMS NIH-NIAID-DAIDS-02-06

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®


RFP ANNOUNCEMENT:  HIV VACCINE DESIGN AND DEVELOPMENT TEAMS NIH-NIAID-DAIDS-02-06

Release Date:  March 5, 2001

NOTICE:  NOT-AI-01-019

National Institute of Allergy and Infectious Diseases

Receipt Date:  July 9, 2001

The Division of Acquired Immune Deficiency Syndrome (DAIDS) of the 
National Institute of Allergy and Infectious Diseases (NIAID), National 
Institutes of Health (NIH), has a requirement for the development of an 
efficacious vaccine against HIV for worldwide use in stemming the AIDS 
epidemic.  To augment the vaccine product pipeline, we are seeking 
opportunities to advance vaccine concepts toward the product stage via 
a focused, development-based approach.  Specifically, the long-range 
goal of this solicitation is the development of new safe and 
immunogenic vaccine candidates that merit further evaluation in larger 
human trials. The HIV Vaccine Design and Development Teams (HVDDT) 
solicitation seeks to fund consortia of scientists with development 
experience from industry and/or academia that have 1) identified a 
promising vaccine concept, and 2) envisioned its targeted development 
into a vaccine product.

A vaccine product is defined here to be a material and its manner of 
administration that could reasonably provide protection against AIDS.  
Offerors are encouraged, but not required to conduct phase I/II trials 
in collaboration with NIAID/DAIDS-supported HIV/AIDS vaccine trials 
networks.  Support for phase III studies will not be funded under this 
solicitation.

It is anticipated that up to six (6) cost reimbursement, completion 
type contracts will be awarded for a period of five (5) years, 
beginning approximately February 15, 2002.  RFP-NIH-NIAID-DAIDS-02-06 
will be available electronically on or about March 12, 2001, and may be 
accessed through the NIAID Contract Management Branch (CMB) Home Page 
using the following address http://www.niaid.nih.gov/contract/. Select 
the link  RFPs  and then select  RFP-NIH-NIAID-DAIDS-02-06.   Please 
note that the RFP for this acquisition has been revised to include only 
the Work Statement, deliverable and reporting requirements, special 
requirements and mandatory qualification, if any, the Technical 
Evaluation Criteria, and the proposal preparation instructions.  All 
information required for the submission of an offer will be contained 
in the electronic RFP package.  Following proposal submission and the 
initial review process, Offerors comprising the competitive range will 
be requested to provide additional documentation to the Contracting 
Officer.

Responses to this RFP will be due on July 9, 2001.  Any responsible 
Offeror may submit a proposal that will be considered by the 
Government.

This advertisement does not commit the Government to award a contract.

Point of Contact:  Joshua LaVine, Contract Specialist
Email:  [email protected]
Tel:  301-496-2509 (via tty 1-800-735-2258)
FAX:  301-402-0972

No collect calls will be accepted.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices